ORGO FY 2021 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$355M

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$467M+38.2% YoY

Gross Profit

$353M75.6% margin

Operating Income

$72M15.5% margin

Net Income

$94M20.2% margin

EPS (Diluted)

$0.70

Cash Flow

Operating Cash Flow

$62M

Free Cash Flow

$31M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$443M

Total Liabilities

$202M

Stockholders' Equity

$241M

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$467M	$338M	+38.2%
Gross Profit	$353M	$251M	+40.7%
Operating Income	$72M	$27M	+170.5%
Net Income	$94M	$17M	+446.6%